| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.decipherlabs.in | |
| Market Cap | 16.81 Cr. | |
| Enterprise Value(EV) | 16.63 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -7.08 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.30 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 20.41 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 0.82 | Calculated using Price: 16.64 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.01 Cr. | 10,100,000 Shares |
| FaceValue | 10 | |
| About Decipher Labs Ltd. | ||
| Combat is a professionally managed, well established public limited company, engaged in the manufacture & marketing of Pharmaceutical Formulations since its incorporation in 1986. The company has been marketing its branded formulations and entering into agreements with various companies for custom manufacturing and has grown to be known as a quality provider. | ||
| 1 Day |
|
+1.10% |
| 1 Week |
|
+4.37% |
| 1 Month |
|
+3.78% |
| 3 Month |
|
-18.46% |
| 6 Month |
|
+2.30% |
| 1 Year |
|
-14.96% |
| 2 Year |
|
-70.86% |
| 5 Year |
|
-36.62% |
| 10 Year |
|
+91.63% |
| 6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 8.6 | 17.45 | 14.59 | 10.69 | 60.15 | -11.32 | |
| Return on Capital Employed (%) | 8.1 | 17.95 | 18.11 | 13.09 | 40.71 | -12.54 | |
| Return on Assets (%) | 6.16 | 8.71 | 5.28 | 3.79 | 28.24 | -7.76 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 2 | 3 | 13 | 14 | 24 | 23 | 21 | |
| Non Curr. Liab. | 1 | 8 | 7 | -1 | -1 | |||
| Curr. Liab. | 1 | 4 | 21 | 17 | 11 | 5 | 3 | |
| Minority Int. | ||||||||
| Equity & Liab. | 3 | 6 | 35 | 39 | 42 | 27 | 23 | |
| Non Curr. Assets | 0 | 13 | 16 | 4 | 7 | 7 | ||
| Curr. Assets | 3 | 6 | 23 | 23 | 38 | 20 | 17 | |
| Misc. Exp. not W/O | ||||||||
| Total Assets | 3 | 6 | 35 | 39 | 42 | 27 | 23 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 1 | 8 | 24 | 56 | 65 | 46 | 35 | |
| Other Income | 0 | 0 | 1 | 8 | 7 | 0 | ||
| Total Income | 1 | 8 | 24 | 56 | 73 | 53 | 35 | |
| Total Expenditure | -1 | -8 | -21 | -52 | -59 | -54 | -41 | |
| PBIDT | 0 | 0 | 3 | 4 | 14 | -1 | -6 | |
| Interest | 0 | -1 | -1 | 0 | 0 | 0 | ||
| Depreciation | -1 | -1 | -1 | 0 | 0 | |||
| Taxation | 0 | 0 | -1 | -1 | 1 | -1 | ||
| Exceptional Items | -2 | |||||||
| PAT | 0 | 0 | 1 | 1 | 11 | -3 | -7 | |
| Minority Interest | ||||||||
| Share Associate | ||||||||
| Other Related Items | ||||||||
| Consolidated Net Profit | 0 | 0 | 1 | 1 | 11 | -3 | -7 | |
| Adjusted EPS | 0 | 1 | 1 | 1 | 11 | -3 | -7 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | -15 | 2 | 8 | -2 | |
| Cash Fr. Inv. | 0 | 0 | 0 | 0 | -4 | ||
| Cash Fr. Finan. | 0 | 0 | 16 | 4 | 1 | -2 | |
| Net Change | 0 | 0 | 1 | 6 | 9 | -8 | |
| Cash & Cash Eqvt | 0 | 0 | 1 | 7 | 15 | 7 |
|
Sat, 20 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.
Date: 20/04/2024 |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Fri, 19 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Siva Kumar Reddy Chappidi Designation: Company Secretary and Compliance Officer EmailId: cs@decipherlabs.in Name of the Chief Financial Officer: Sonam Jalan Designation: Chief Financial Officer EmailId: sonam.jalan@intlcap.net Date: 19/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Mon, 15 Apr 2024
Compliance As Per Regulation 40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31.03.2024. Compliance as per Regulation 40(10) of SEBI(LODR) Regulations 2015 |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Wed, 24 Apr 2024 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
